Target intelligence / Profile preview

RNA, U6 small nuclear 910, pseudogene (RNU6-910P)

Target
RNU6-910P
Molecular classification
Other (non-coding RNA pseudogene; derived from snRNA gene family)
01

Overview

RNU6-910P is a non-protein coding pseudogene derived from the U6 small nuclear RNA gene family. Functional U6 snRNA is highly conserved and essential to the splicing activity that removes introns from pre-mRNA in eukaryotes, serving as a core catalytic RNA in the spliceosome[1][3]. Pseudogenes like RNU6-910P represent inactive, often non-transcribed genomic copies that lack the capacity to produce the functional snRNA and, consequently, do not participate in splicing or other cellular processes. They are not considered receptors, enzymes, transporters, nor canonical drug targets and do not possess known endogenous functions or clinical implications as disease-associated loci. Their identification may be relevant in genomic annotation but not in therapeutic targeting or disease biology[1][4].

Other names
RNU6-910PRNA, U6 small nuclear RNA 910, pseudogene
02

Mechanism of action

None (no drugs or direct mechanisms identified)

03

Biological functions

None (for RNU6-910P specifically, as a pseudogene)Related functions of functional counterparts: splicing (pre-mRNA), snRNA binding
04

Disease associations

None specific for RNU6-910P documentedRegulated pseudogenes in general may influence gene expression through competing endogenous RNA (ceRNA) effects or epigenetic regulation, but there is no evidence for this specific pseudogene in disease
05

Safety considerations

None (no safety, toxicity, or therapeutic challenges are associated)
06

Interacting drugs

None (no known drugs interact with pseudogenes like RNU6-910P)
07

Biomarkers

None (this pseudogene is not used as a biomarker)

Beyond the preview

Go deeper on RNA, U6 small nuclear 910, pseudogene (RNU6-910P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 910, pseudogene (RNU6-910P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call